Overview

Modified Vaccinia Ankara (MVA) Vaccine Study

Status:
Completed

Trial end date:
2010-09-01

Target enrollment:

Participant gender:

Summary

This is a phase I, dose escalation trial of MVA-EBNA1/LMP2 vaccine across a pre-defined range of doses in patients in remission having had an EBV+ nasopharyngeal carcinoma (NPC).

Phase:

Phase 1

Details

Lead Sponsor:

Chinese University of Hong Kong

Treatments:

Vaccines